Skip to content

Ultrasound-Guided Internal Superior Laryngeal Nerve Block for Double-Lumen Bronchial Tube

Effect of Ultrasound-Guided Internal Superior Laryngeal Nerve Block on Sore Throat After Intubation by Double-Lumen Bronchial Tube for Thoracoscopic Surgery

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05825872
Enrollment
64
Registered
2023-04-24
Start date
2023-04-05
Completion date
2023-09-05
Last updated
2023-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Sore Throat

Brief summary

investigate the effectiveness and safety of ultrasound-guided bilateral internal branch of the SLN (iSLN) block for alleviating POST immediately after the operation.

Interventions

1.5 ml will be injected

PROCEDUREinternal superior laryngeal nerve block

A linear 4- to 12-MHz ultrasound probe will be placed in the oblique parasagittal plane to obtain an image of the hyoid bone and the thyroid cartilage. The probe will be kept parasagitally, and the following structures will be identified anteriorly to posteriorly: omohyoid muscle, sternohyoid muscle, thyrohyoid muscle, thyrohyoid membrane, superior laryngeal artery, and pre-epiglottis space. After identifying the local anatomic structure, a needle will be inserted out-plane from anterior to posterior. The muscles above the thyrohyoid membrane will be penetrated and hydrodissected; local anesthetic will be injected into the superior laryngeal nerve space. The superior laryngeal nerve space will be located between the hyoid bone (cephalad) and the thyroid cartilage (caudal) and delimited between the thyrohyoid muscle, anteriorly, and the thyrohyoid membrane and the pre-epiglottis space, posteriorly

0.5 ml will be injected

Sponsors

Menoufia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* ASA 1 to 3

Exclusion criteria

* patients who did not provide consent * with a pre-existing sore throat, hoarseness and upper respiratory tract infection * tracheal pathology, tracheostomy * a history of psychosis, diabetes and thyroid, oral cavity or pharynx surgery * known or suspected allergy to ropivacaine * chronic opioid use * use of nonsteroidal anti-inflammatory drug medication within 24 hours * known or suspected difficult airway * patients who will be supported by tube ventilator after the operation.

Design outcomes

Primary

MeasureTime frameDescription
the pain classification of postoperative sore throatfrom immediate postoperative till 24 hours postoperativean established scoring system feom 0 to 4

Countries

Egypt

Contacts

Primary Contactmostafa S mansour, MD
mostafa.said@med.menofia.edu.eg00201225484055
Backup Contactislam M el-desoky, MD
00201092447887

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026